Bioequivalence of a biosimilar enoxaparin sodium to Clexane® after single 100 mg subcutaneous dose: results of a randomized, double-blind, crossover study in healthy volunteers

• Ngā kaituhi matua: Martínez González J (Author), Monreal M (Author), Ayani Almagia I (Author), Llaudó Garín J (Author), Ochoa Díaz de Monasterioguren L (Author), Gutierro Adúriz I (Author)
• Hōputu: Pukapuka
• I whakaputaina: Dove Medical Press, 2018-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Javier Martínez González, Mayte Monreal, Ignacio Ayani Almagia, Jordi Llaudó Garín, Lourdes Ochoa Díaz de Monasterioguren, Ibón Gutierro Adúriz R&D Department, Laboratorios Farmacéuticos Rovi S.A., Madrid, Spain Purpose: To demonstrate the pharmacokinetic/pharmacodynamic (PK/PD) equivalence of a...